Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
14.60
+0.51 (3.62%)
Dec 5, 2025, 4:00 PM EST - Market closed
Enanta Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Enanta Pharmaceuticals stock have an average target of 20.4, with a low estimate of 12 and a high estimate of 28. The average target predicts an increase of 39.73% from the current stock price of 14.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Enanta Pharmaceuticals stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 3 | 4 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $17 | Buy | Initiates | $17 | +16.44% | Nov 14, 2025 |
| WestPark Capital | WestPark Capital | Strong Buy Maintains $24 → $28 | Strong Buy | Maintains | $24 → $28 | +91.78% | Sep 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $20 → $12 | Buy | Maintains | $20 → $12 | -17.81% | Sep 15, 2025 |
| WestPark Capital | WestPark Capital | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +64.38% | Sep 2, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $24 → $25 | Buy | Maintains | $24 → $25 | +71.23% | Aug 12, 2025 |
Financial Forecast
Revenue This Year
65.97M
from 65.32M
Increased by 0.99%
Revenue Next Year
66.10M
from 65.97M
Increased by 0.19%
EPS This Year
-3.10
from -3.84
EPS Next Year
-2.55
from -3.10
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 74.4M | 80.9M | |||
| Avg | 66.0M | 66.1M | |||
| Low | 57.3M | 53.7M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.0% | 22.6% | |||
| Avg | 1.0% | 0.2% | |||
| Low | -12.2% | -18.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -2.29 | -1.51 | |||
| Avg | -3.10 | -2.55 | |||
| Low | -4.38 | -3.74 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.